Click Here for 5% Off Your First Aladdin Purchase!

OS2966 (anti-ITGB1) - Primary antibody, specific to ITGB1, >95%, high purity, Human IgG1

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Human
  • Isotype: Human IgG1
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab177919
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab177919-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab177919-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$519.90
Ab177919-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,399.90
Ab177919-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,239.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameOS2966 (anti-ITGB1) - Primary antibody, specific to ITGB1, >95%, high purity, Human IgG1
Synonymsbeta1 integrin antibody; CD_antigen=CD29 antibody; CD29 antibody; Fibronectin receptor subunit beta antibody; FNRB antibody; Glycoprotein IIa antibody; GP IIa antibody; GPIIA antibody; Integrin beta-1 antibody; Integrin subunit beta 1 antibody; integrin V
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityITGB1
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Product Description

OS2966 (anti-ITGB1) is a humanized monoclonal antibody directed against the human integrin receptor beta-1 subunit (CD29), with potential antineoplastic activity.

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE26.3 kDa (Light Chain) & 51.5 kDa (Heavy Chain), under reducing conditions; 176.1 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95%
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.

Images

OS2966 (anti-ITGB1) (Ab177919) - Flow Cytometry
Flow Cytometry analysis of U-2 OS cells labelling ITGB1 (red) with OS2966 (anti-ITGB1) (Ab177919). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

OS2966 (anti-ITGB1) (Ab177919) - Flow Cytometry
Flow Cytometry analysis of Hela cells labelling ITGB1 (red) with OS2966 (anti-ITGB1) (Ab177919). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

OS2966 (anti-ITGB1) (Ab177919) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling ITGB1 (red) with OS2966 (anti-ITGB1) (Ab177919). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

OS2966 (anti-ITGB1) (Ab177919) - SEC
The purity of OS2966 (anti-ITGB1) (Ab177919) is more than 95% verified by HPLC.

OS2966 (anti-ITGB1) (Ab177919) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling ITGB1 with OS2966 (anti-ITGB1) (Ab177919) conjugated with biotin (right panel) compared with Human IgG (Ab170213) conjugated with biotin - Isotype Control (left panel) and detected with SA-PE (rp156250).

OS2966 (anti-ITGB1) (Ab177919) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling ITGB1 (red) with OS2966 (anti-ITGB1) (Ab177919) conjugated with biotin and detected with SA-PE (rp156250). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.

Associated Targets

ITGB1 Tclin Integrin beta-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0404072Certificate of AnalysisApr 02, 2024 Ab177919
ZJ24F0404071Certificate of AnalysisApr 02, 2024 Ab177919
ZJ24F0404070Certificate of AnalysisApr 02, 2024 Ab177919

Related Documents

References

1. Lin Kc, Ateeq HS, Hsiung SH, Chong LT, Zimmerman CN, Castro A, Lee WC, Hammond CE, Kalkunte S, Chen LL et al..  (1999)  Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses..  J Med Chem,  42  (5): (920-34).  [PMID:10072689]
2. No authors listed.  (2004)  Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody..  Drugs R D,  (2): (102-7).  [PMID:15293871]
3. Bhaskar V, Fox M, Breinberg D, Wong MH, Wales PE, Rhodes S, DuBridge RB, Ramakrishnan V.  (2008)  Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits..  Invest New Drugs,  26  (1): (7-12).  [PMID:17786386]
4. Bhaskar V, Zhang D, Fox M, Seto P, Wong MH, Wales PE, Powers D, Chao DT, Dubridge RB, Ramakrishnan V.  (2007)  A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo..  J Transl Med,  (3): (61).  [PMID:18042290]
5. Grove RA, Shackelford S, Sopper S, Pirruccello S, Horrigan J, Havrdova E, Gold M, Graff O.  (2013)  Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis..  Eur J Neurol,  20  (7): (1032-42).  [PMID:23419064]
6. Wolf C, Sidhu J, Otoul C, Morris DL, Cnops J, Taubel J, Bennett B.  (2013)  Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study..  PLoS One,  (3): (e58438).  [PMID:23472197]
7. Nissinen L, Koivunen J, Käpylä J, Salmela M, Nieminen J, Jokinen J, Sipilä K, Pihlavisto M, Pentikäinen OT, Marjamäki A et al..  (2012)  Novel α2β1 integrin inhibitors reveal that integrin binding to collagen under shear stress conditions does not require receptor preactivation..  J Biol Chem,  287  (53): (44694-702).  [PMID:23132859]
8. Masaki Setoguchi,Shin Iimura,Yuuichi Sugimoto,Yoshiyuki Yoneda,Jun Chiba,Toshiyuki Watanabe,Fumihito Muro,Yutaka Iigo,Gensuke Takayama,Mika Yokoyama,Tomoe Taira,Misato Aonuma,Tohru Takashi,Atsushi Nakayama,Nobuo Machinaga.  (2012-12-12)  A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid..  Bioorganic & medicinal chemistry,  21  ((1)): (42-61).  [PMID:23218775]
9. Francis Impens,Lilliana Radoshevich,Pascale Cossart,David Ribet.  (2014-08-13)  Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli..  Proceedings of the National Academy of Sciences of the United States of America,  111  ((34)): (12432-12437).  [PMID:25114211]
10. Miller WH, Bondinell WE, Cousins RD, Erhard KF, Jakas DR, Keenan RM, Ku TW, Newlander KA, Ross ST, Haltiwanger RC, Bradbeer J, Drake FH, Gowen M, Hoffman SJ, Hwang SM, James IE, Lark MW, Lechowska B, Rieman DJ, Stroup GB, Vasko-Moser JA, Zembryki DL, Azzarano LM, Adams PC, Huffman WF..  (1999)  Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model..  Bioorg Med Chem Lett,  (13): (1807-1812).  [PMID:10406646]
11. Chang LL, Truong Q, Mumford RA, Egger LA, Kidambi U, Lyons K, McCauley E, Van Riper G, Vincent S, Schmidt JA, MacCoss M, Hagmann WK..  (2002)  The discovery of small molecule carbamates as potent dual alpha(4)beta(1)/alpha(4)beta(7) integrin antagonists..  Bioorg Med Chem Lett,  12  (2): (159-163).  [PMID:11755344]
12. Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H..  (2004)  Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents..  Bioorg Med Chem Lett,  14  (10): (2505-2509).  [PMID:15109641]
13. Jackson DY, Quan C, Artis DR, Rawson T, Blackburn B, Struble M, Fitzgerald G, Chan K, Mullins S, Burnier JP, Fairbrother WJ, Clark K, Berisini M, Chui H, Renz M, Jones S, Fong S..  (1997)  Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents..  J Med Chem,  40  (21): (3359-3368).  [PMID:9341911]
14. Boer J, Gottschling D, Schuster A, Semmrich M, Holzmann B, Kessler H..  (2001)  Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists..  J Med Chem,  44  (16): (2586-2592).  [PMID:11472212]
15. Singh J, Van Vlijmen H, Liao Y, Lee WC, Cornebise M, Harris M, Shu IH, Gill A, Cuervo JH, Abraham WM, Adams SP..  (2002)  Identification of potent and novel alpha4beta1 antagonists using in silico screening..  J Med Chem,  45  (14): (2988-2993).  [PMID:12086484]
16. Gong Y, Barbay JK, Dyatkin AB, Miskowski TA, Kimball ES, Prouty SM, Fisher MC, Santulli RJ, Schneider CR, Wallace NH, Ballentine SA, Hageman WE, Masucci JA, Maryanoff BE, Damiano BP, Andrade-Gordon P, Hlasta DJ, Hornby PJ, He W..  (2006)  Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists..  J Med Chem,  49  (11): (3402-3411).  [PMID:16722660]
17. Carpenter RD, Andrei M, Aina OH, Lau EY, Lightstone FC, Liu R, Lam KS, Kurth MJ..  (2009)  Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin..  J Med Chem,  52  (1): (14-19).  [PMID:19072684]
18. Hall PR, Leitão A, Ye C, Kilpatrick K, Hjelle B, Oprea TI, Larson RS..  (2010)  Small molecule inhibitors of hantavirus infection..  Bioorg Med Chem Lett,  20  (23): (7085-7091).  [PMID:20951038]
19. Tolomelli A, Baiula M, Viola A, Ferrazzano L, Gentilucci L, Dattoli SD, Spampinato S, Juaristi E, Escudero M..  (2015)  Dehydro-β-proline Containing α4β1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay..  ACS Med Chem Lett,  (6): (701-706).  [PMID:26101577]
20. Qin N, Jia M, Wu XR, Shou XA, Liu Q, Gan CC, Jin MN, Yu Y, Duan HQ..  (2016)  Synthesis and anti-metastatic effects of pregn-17(20)-en-3-amine derivatives..  Eur J Med Chem,  124  (490-499).  [PMID:27598237]
21. Bhunia SS, Misra A, Khan IA, Gaur S, Jain M, Singh S, Saxena A, Hohlfield T, Dikshit M, Saxena AK..  (2017)  Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles..  J Med Chem,  60  (1): (322-337).  [PMID:27996269]
22. Merlino F, Daniele S, La Pietra V, Di Maro S, Di Leva FS, Brancaccio D, Tomassi S, Giuntini S, Cerofolini L, Fragai M, Luchinat C, Reichart F, Cavallini C, Costa B, Piccarducci R, Taliani S, Da Settimo F, Martini C, Kessler H, Novellino E, Marinelli L..  (2018)  Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme..  J Med Chem,  61  (11): (4791-4809).  [PMID:29775303]
23. Languino, L R LR and Ruoslahti, E E..  (1992)  An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain..  The Journal of biological chemistry,    (5):   [PMID:1551917]
24. Altruda, F F and 6 more authors..  (1990)  A human integrin beta 1 subunit with a unique cytoplasmic domain generated by alternative mRNA processing..  Gene,    (15):   [PMID:2249781]
25. Argraves, W S WS and 5 more authors..  (1987)  Amino acid sequence of the human fibronectin receptor..  The Journal of cell biology,      [PMID:2958481]
26. Balzac, F F and 7 more authors..  (1994)  Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility..  The Journal of cell biology,      [PMID:7523423]
27. van der Flier, A A, Kuikman, I I, Baudoin, C C, van der Neut, R R and Sonnenberg, A A..  (1995)  A novel beta 1 integrin isoform produced by alternative splicing: unique expression in cardiac and skeletal muscle..  FEBS letters,    (7):   [PMID:7544298]
28. Zhidkova, N I NI, Belkin, A M AM and Mayne, R R..  (1995)  Novel isoform of beta 1 integrin expressed in skeletal and cardiac muscle..  Biochemical and biophysical research communications,    (5):   [PMID:7545396]
29. Balzac, F F and 6 more authors..  (1993)  Expression and functional analysis of a cytoplasmic domain variant of the beta 1 integrin subunit..  The Journal of cell biology,      [PMID:7681433]
30. Belkin, A M AM and 8 more authors..  (1996)  Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells..  The Journal of cell biology,      [PMID:8567725]
31. Svineng, G G, Fässler, R R and Johansson, S S..  (1998)  Identification of beta1C-2, a novel variant of the integrin beta1 subunit generated by utilization of an alternative splice acceptor site in exon C..  The Biochemical journal,    (15):   [PMID:9494094]
32. Sasaki, T T, Brakebusch, C C, Engel, J J and Timpl, R R..  (1998)  Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin..  The EMBO journal,    (16):   [PMID:9501082]
33. Barillari, G G and 10 more authors..  (1999)  The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor..  Blood,    (15):   [PMID:10397733]
34. Mueller, S C SC and 8 more authors..  (1999)  A novel protease-docking function of integrin at invadopodia..  The Journal of biological chemistry,    (27):   [PMID:10455171]
35. Li, J J, Mayne, R R and Wu, C C..  (1999)  A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation..  The Journal of cell biology,    (27):   [PMID:10613898]
36. Zhang, J J, Clatterbuck, R E RE, Rigamonti, D D, Chang, D D DD and Dietz, H C HC..  (2001)  Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation..  Human molecular genetics,    (1):   [PMID:11741838]
37. van der Flier, Arjan A and 7 more authors..  (2002)  Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin [beta] subunits..  The Journal of cell biology,    (21):   [PMID:11807098]
38. Degani, Simona S and 7 more authors..  (2002)  The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading..  The Journal of cell biology,    (21):   [PMID:11807099]
39. Fournier, Henri-Noël HN and 6 more authors..  (2002)  Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha ) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement..  The Journal of biological chemistry,    (7):   [PMID:11919189]
40. Bouvard, Daniel D and 8 more authors..  (2003)  Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1 alpha..  The Journal of biological chemistry,    (21):   [PMID:12473654]
41. Lin, Cristiane G CG and 6 more authors..  (2003)  CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family..  The Journal of biological chemistry,    (27):   [PMID:12695522]
42. Bax, Daniel V DV and 7 more authors..  (2003)  Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins..  The Journal of biological chemistry,    (5):   [PMID:12807887]
43. Weigel-Kelley, Kirsten A KA, Yoder, Mervin C MC and Srivastava, Arun A..  (2003)  Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry..  Blood,    (1):   [PMID:12907437]
44. Denti, Simona S and 8 more authors..  (2004)  RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1..  The Journal of biological chemistry,    (26):   [PMID:14722085]
45. Zhang, Hongquan H and 8 more authors..  (2004)  Myosin-X provides a motor-based link between integrins and the cytoskeleton..  Nature cell biology,      [PMID:15156152]
46. Deloukas, P P and 135 more authors..  (2004)  The DNA sequence and comparative analysis of human chromosome 10..  Nature,    (27):   [PMID:15164054]
47. Fukushi, Jun-ichi J, Makagiansar, Irwan T IT and Stallcup, William B WB..  (2004)  NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin..  Molecular biology of the cell,      [PMID:15181153]
48. Lin, Qishan Q, Keller, Rebecca S RS, Weaver, Barbara B and Zisman, Lawrence S LS..  (2004)  Interaction of ACE2 and integrin beta1 in failing human heart..  Biochimica et biophysica acta,    (4):   [PMID:15276642]
49. Gontier, Yves Y and 7 more authors..  (2005)  The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins..  Journal of cell science,    (15):   [PMID:16076904]
50. Maginnis, Melissa S MS and 8 more authors..  (2006)  Beta1 integrin mediates internalization of mammalian reovirus..  Journal of virology,      [PMID:16501085]
51. Pellinen, Teijo T and 5 more authors..  (2006)  Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins..  The Journal of cell biology,    (5):   [PMID:16754960]
52. Chi, An A and 16 more authors..  (2006)  Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes..  Journal of proteome research,      [PMID:17081065]
53. Jovanovic, Jelena J and 7 more authors..  (2007)  alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative studies of molecular determinants underlying integrin-rgd affinity and specificity..  The Journal of biological chemistry,    (2):   [PMID:17158881]
54. Katz, Menachem M and 22 more authors..  (2007)  A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration..  Nature cell biology,      [PMID:17643115]
55. Caswell, Patrick T PT and 12 more authors..  (2007)  Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments..  Developmental cell,      [PMID:17925226]
56. Chuang, N-N NN and Huang, C-C CC..  (2007)  Interaction of integrin beta1 with cytokeratin 1 in neuroblastoma NMB7 cells..  Biochemical Society transactions,      [PMID:17956333]
57. Saegusa, Jun J and 8 more authors..  (2008)  Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner..  The Journal of biological chemistry,    (19):   [PMID:18635536]
58. Pellinen, Teijo T and 12 more authors..  (2008)  Integrin trafficking regulated by Rab21 is necessary for cytokinesis..  Developmental cell,      [PMID:18804435]
59. Luissint, Anny-Claude AC, Lutz, Pierre G PG, Calderwood, David A DA, Couraud, Pierre-Olivier PO and Bourdoulous, Sandrine S..  (2008)  JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation..  The Journal of cell biology,    (15):   [PMID:19064666]
60. Wollscheid, Bernd B and 7 more authors..  (2009)  Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins..  Nature biotechnology,      [PMID:19349973]
61. Feire, Adam L AL, Roy, René M RM, Manley, Kate K and Compton, Teresa T..  (2010)  The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry..  Journal of virology,      [PMID:20660204]
62. Qu, Hong H and 9 more authors..  (2011)  Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with phosphoinositides and integrins..  Journal of cell science,    (15):   [PMID:21325030]
63. Nägele, Virginie V and 5 more authors..  (2011)  Neisseria meningitidis adhesin NadA targets beta1 integrins: functional similarity to Yersinia invasin..  The Journal of biological chemistry,    (10):   [PMID:21471204]
64. Yu, Xue X and 13 more authors..  (2011)  ACAP4 protein cooperates with Grb2 protein to orchestrate epidermal growth factor-stimulated integrin β1 recycling in cell migration..  The Journal of biological chemistry,    (23):   [PMID:22027826]
65. Nagae, Masamichi M and 5 more authors..  (2012)  Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor..  The Journal of cell biology,    (2):   [PMID:22451694]
66. Bai, Ming M and 8 more authors..  (2012)  Mechanistic insights into regulated cargo binding by ACAP1 protein..  The Journal of biological chemistry,    (17):   [PMID:22645133]
67. Fujita, Masaaki M, Takada, Yoko K YK and Takada, Yoshikazu Y..  (2012)  Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1..  Journal of immunology (Baltimore, Md. : 1950),    (15):   [PMID:23125415]
68. Liu, Weizhi W, Draheim, Kyle M KM, Zhang, Rong R, Calderwood, David A DA and Boggon, Titus J TJ..  (2013)  Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation..  Molecular cell,    (21):   [PMID:23317506]
69. Fujita, Masaaki M, Takada, Yoko K YK and Takada, Yoshikazu Y..  (2014)  The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site..  PloS one,      [PMID:24789099]
70. Muharram, Ghaffar G and 8 more authors..  (2014)  Tensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells..  Developmental cell,    (27):   [PMID:24814316]
71. Fujita, Masaaki M and 7 more authors..  (2015)  Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1..  The Journal of biological chemistry,    (2):   [PMID:25398877]
72. Takada, Yoko K YK and 5 more authors..  (2017)  Direct binding to integrins and loss of disulfide linkage in interleukin-1β (IL-1β) are involved in the agonistic action of IL-1β..  The Journal of biological chemistry,    (8):   [PMID:29030430]
73. Takada, Yoko K; Yu, Jessica; Shimoda, Michiko and Takada, Yoshikazu..  (2019)  Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling..  Journal of immunology (Baltimore, Md. : 1950),    (1):   [PMID:31331973]
74. Alqarihi, Abdullah and 10 more authors..  (2020)  GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis..  mBio,    (2):   [PMID:32487760]
75. Beddingfield, Brandon J and 7 more authors..  (2021)  The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection..  JACC. Basic to translational science,      [PMID:33102950]

Solution Calculators